200 related articles for article (PubMed ID: 17244188)
1. The missing ApoE allele.
Seripa D; Matera MG; Daniele A; Bizzarro A; Rinaldi M; Gravina C; Bisceglia L; Corbo RM; Panza F; Solfrizzi V; Fazio VM; Forno GD; Masullo C; Dallapiccola B; Pilotto A
Ann Hum Genet; 2007 Jul; 71(Pt 4):496-500. PubMed ID: 17244188
[TBL] [Abstract][Full Text] [Related]
2. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.
Viiri LE; Viiri KM; Ilveskoski E; Huhtala H; Mäki M; Tienari PJ; Perola M; Lehtimäki T; Karhunen PJ
Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552
[TBL] [Abstract][Full Text] [Related]
3. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample.
Koch W; Hoppmann P; Schömig A; Kastrati A
Int J Cardiol; 2008 Mar; 125(1):116-7. PubMed ID: 17433475
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein epsilon4 allele is associated with psoriasis severity.
Coto-Segura P; Coto E; Alvarez V; Morales B; Soto-Sánchez J; Corao AI; Santos-Juanes J
Arch Dermatol Res; 2010 Mar; 302(2):145-9. PubMed ID: 19911187
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
7. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
8. The genetics of the human APOE polymorphism.
Seripa D; D'Onofrio G; Panza F; Cascavilla L; Masullo C; Pilotto A
Rejuvenation Res; 2011 Oct; 14(5):491-500. PubMed ID: 21958003
[TBL] [Abstract][Full Text] [Related]
9. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
[TBL] [Abstract][Full Text] [Related]
10. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls.
Niu W; Qi Y; Qian Y; Gao P; Zhu D
Hypertens Res; 2009 Dec; 32(12):1060-6. PubMed ID: 19816504
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype and cerebral palsy.
Braga LW; Borigato EV; Speck-Martins CE; Imamura EU; Gorges AM; Izumi AP; Dantas RC; Nunes LG
Dev Med Child Neurol; 2010 Jul; 52(7):666-71. PubMed ID: 20002130
[TBL] [Abstract][Full Text] [Related]
12. Distribution of APOE genotypes in a memory clinic cohort.
van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
14. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC
Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439
[TBL] [Abstract][Full Text] [Related]
15. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene.
Fritsche LG; Freitag-Wolf S; Bettecken T; Meitinger T; Keilhauer CN; Krawczak M; Weber BH
Hum Mutat; 2009 Jul; 30(7):1048-53. PubMed ID: 19384966
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease.
Blesa R; Aguilar M; Casanova JP; Boada M; Martínez S; Alom J; de la Hoz CH; Sancho J; Fernández O; Gil-Neciga E; Massó JF
Alzheimer Dis Assoc Disord; 2006; 20(4):248-54. PubMed ID: 17132969
[TBL] [Abstract][Full Text] [Related]
17. Association between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in Maracaibo, Zulia state, Venezuela.
Arráiz N; Bermúdez V; Prieto C; Sánchez MP; Escalona C; Sanz E; Rondón N; Reyes F; Velasco M
Am J Ther; 2010; 17(3):330-6. PubMed ID: 20019593
[TBL] [Abstract][Full Text] [Related]
18. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
20. Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.
Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y
Oncotarget; 2017 Jul; 8(27):43721-43732. PubMed ID: 28487499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
